Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Godavari Lifesciences Ltd
NSE: GODAVARILSBSE: 548248Pharma Formulations
₹883.50
▲ 4.70 (+0.53%)
Quarterly Results
- Jun '25: 1,461
- Sep '25: 1,525
- Dec '25: 1,510
- Mar '26: 1,708
- Jun '26: 1,683
- Jun '25: 243
- Sep '25: 254
- Dec '25: 251
- Mar '26: 284
- Jun '26: 293
- Jun '25: ₹7.66
- Sep '25: ₹8.00
- Dec '25: ₹7.92
- Mar '26: ₹8.96
- Jun '26: ₹9.24
| ₹ Cr | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue from operations | 1,461 | 1,525 | 1,510 | 1,708 | 1,683 |
| Operating expenses | 1,104 | 1,153 | 1,142 | 1,292 | 1,251 |
| Operating profit (EBITDA) | 356 | 372 | 369 | 417 | 433 |
| Other income | 15 | 16 | 15 | 17 | 14 |
| Depreciation | 48 | 50 | 49 | 56 | 56 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 324 | 338 | 335 | 379 | 391 |
| Tax | 81 | 85 | 84 | 95 | 98 |
| Net profit | 243 | 254 | 251 | 284 | 293 |
| EPS (₹) | 7.66 | 8.00 | 7.92 | 8.96 | 9.24 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 12 periods. Premium unlocks the full 10-year history. See Premium